-
TrimetaziDine as a Performance-enhancING drug in heart failure with preserved ejection fraction (DoPING-HFpEF): rationale and design of a placebo-controlled cross-over intervention study: rationale and design of a placebo-controlled cross-over intervention study
van de Bovenkamp, A. A., Bakermans, A. J., Allaart, C. P., Nederveen, A. J., Kok, W. E. M., van Rossum, A. C. & Handoko, M. L., 1 Jun 2020, In: Netherlands heart journal. 28, 6, p. 312-319 8 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
